AstraZeneca PLC
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Truqap (capivasertib) — Worldwide YoY CER by Year
Truqap (capivasertib) — Worldwide YoY CER (%) (%)
AstraZeneca Truqap (capivasertib) — Worldwide YoY CER: 68.0% in FY2025.
Latest, FY2025
68.0%
Period ended Dec 31, 2025
Change on a year earlier
–
History
1 years
Since FY2025
Sources
1
Form 6-K FY2025Q4 Earnings Release
Where the FY2025 figure comes from
“|| Truqap | 728 | 69 | 68 | 586 | 44 | 23 | n/m | n/m | 85 | n/m | n/m | 34 | n/m | n/m”
Source: Form 6-K FY2025Q4 Earnings Release ↗
Reported in Form 6-K / 20-F Product Sales Table.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Truqap (capivasertib) — Worldwide YoY CER (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 68.0% | – | Form 6-K FY2025Q4 Earnings Release ↗ |
Cite this data
StockData. (2026). AstraZeneca Truqap (capivasertib) — Worldwide YoY CER (%), annual FY2025–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-truqap-world-cer-yoy
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.